Recall: D-0876-2026
Class II - Potentially Harmful
Class IIClassification
2026-09-08Initiated
OngoingStatus
Par Health USA, LLCFirm
Product
Buprenorphine Hydrochloride, Injection 0.3 mg/mL, Rx Only, 5 x 1 mL Single Dose Vials, Manufactured for: Endo USA, Malvern, PA, NDC 42023-179-05
Reason
Crystallization
Distribution
U.S. Nationwide
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.